Your Health, We Care
In the pursuit of health and recovery, rational use of drugs is a crucial part. Patients should be fully aware of the information about the drug, including but not limited to efficacy, dosage, and contraindications, before using any drug. Be sure to follow the doctor's guidance and do not increase or decrease the dose or change the drug at will, so as not to affect the efficacy or cause adverse reactions; Be aware of drug-drug interactions and avoid self-medication.
The price of lorlatinib varies significantly, mainly depending on the drug sourc···【more】
Release date：2026-01-23Recommended：119
This drug is a prescription medicine. Its use must strictly follow the doctor’s ···【more】
Release date：2026-01-23Recommended：120
The price of Lorlatinib is subject to significant fluctuations due to the impact···【more】
Release date：2026-01-23Recommended：106
The monthly treatment cost of lorlatinib currently available in China fluctuates···【more】
Release date：2026-01-23Recommended：134
Pfizer recently announced that the U.S. Food and Drug Administration (FDA) has a···【more】
Release date：2026-01-23Recommended：167
On March 3, 2021, Pfizer announced that the U.S. Food and Drug Administration (F···【more】
Release date：2026-01-23Recommended：175
At the Presidential Symposium of the 2020 ESMO Annual Congress, results of a hea···【more】
Release date：2026-01-23Recommended：132
In December 2020, the U.S. Food and Drug Administration (FDA) accepted a supplem···【more】
Release date：2026-01-23Recommended：165
Pfizer recently announced that the Phase III CROWN study, which evaluates Lorbre···【more】
Release date：2026-01-23Recommended：146
Lorbrena (generic name: Lorlatinib) is a next-generation tyrosine kinase inhibit···【more】
Release date：2026-01-23Recommended：167
On November 19, 2020, Pfizer announced the positive results of the phase III hea···【more】
Release date：2026-01-23Recommended：135
Pfizer Inc. recently announced that the U.S. Food and Drug Administration (FDA) ···【more】
Release date：2026-01-23Recommended：144
Telegram name: Vira
Name: LUCIUS
No.:0085253923643
